Key result
Combined detection of pPOSTN, pCA125/pPOSTN, and pCA125/sCRP diagnosed malignant pleural effusion caused by NSCLC with an AUC of 0.912, sensitivity of 95.45%, and specificity of 77.50%.
Why the study?
Data were limited regarding the diagnostic value, sensitivity, and specificity of pleural fluid periostin and serum periostin in malignant pleural effusions caused by NSCLC.
Does the measurement of pleural fluid and serum periostin improve the diagnosis of malignant pleural effusion in patients with non-small-cell lung cancer?
Case-Control (n=84)
Does the measurement of pleural fluid and serum periostin improve the diagnosis of malignant pleural effusion in patients with non-small-cell lung cancer?
Answers are grounded in this paper and cite their sources.
Combined detection of pleural fluid and serum periostin with other biomarkers provides high diagnostic accuracy for malignant pleural effusions caused by non-small-cell lung cancer.
BACKGROUND: Limited data are available for the diagnostic value, and the diagnostic sensitivity and specificity of pleural fluid periostin (pPOSTN) and serum periostin (sPOSTN) in malignant pleural effusion (MPE) caused by non-small-cell lung cancer (NSCLC). METHODS: We collected 84 pleural effusion samples, including 44 cases of MPE caused by NSCLC and 40 cases of benign pleural effusions (BPEs) from August 2018 to January 2019. The pPOSTN, sPOSTN, pleural fluid lactate dehydrogenase (pLDH), pleural effusion adenosine deaminase (pADA), pleural effusion total protein (pTP), pleural fluid glucose (pGLU), pleural effusion leukocyte count (pWBC), pleural effusion red cell count (pRBC), pleural effusion carbohydrate antigen 199 (pCA199), pleural fluid carbohydrate antigen 125 (pCA125), pleural effusion ferritin (pFer), serum total protein (sTP), and serum C-reactive protein (sCRP) were tested, and the obtained data were analyzed by statistical software. RESULTS: Compared to the BPE group, the pPOSTN level in the MPE group was observably lower, while the levels of sPOSTN, sPOSTN/pADA, pCA199/pADA, and pCA199/pPOSTN increased. The receiver operating characteristic (ROC) curve showed that the area under the ROC curve (AUC) (=0.844, 0.847, 0.841) of sPOSTN/pADA, pCA199/pADA, and pCA199/pPOSTN (cutoff = 11.86, 0.244, 0.015) was observably higher than other indicators for the diagnosis of MPE caused by NSCLC. Thus, the combined detection of pPOSTN, pCA125/pPOSTN, and pCA125/sCRP suggested that the AUC, sensitivity, and specificity was 0.912%, 95.45%, and 77.50% at the cutoff 0.317 and diagnostic performance was higher than sPOSTN/pADA or pCA199/pADA or pCA199/pPOSTN. CONCLUSION: Combined detection of sPOSTN/pADA, pCA199/pADA, and pCA199/pPOSTN can be used as a good indicator for MPE caused by NSCLC.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2019) conducted a case-control in Malignant pleural effusion caused by non-small-cell lung cancer (n=84). Combined detection of pPOSTN, pCA125/pPOSTN, and pCA125/sCRP vs. Benign pleural effusions was evaluated on Diagnosis of malignant pleural effusion caused by NSCLC (AUC 0.912). Combined detection of pPOSTN, pCA125/pPOSTN, and pCA125/sCRP diagnosed malignant pleural effusion caused by NSCLC with an AUC of 0.912, sensitivity of 95.45%, and specificity of 77.50%.
Synapse has enriched 10 related papers. Consider them for comparative context: